ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Growth - Direct Plan

NAV 39.40(1.52%)
Apr 03, 2025
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Growth - Direct Plan
AUM
₹4,611 Cr
Expense (%)
1.11
Turnover (%)
95.00
Benchmark
BSE Health Care - TRI
Asset Quality
Large, Green
Differs from benchmark (%)
95.24

3Yr Rolling Returns(%)

Benchmark# : undefined
                                                                                                                                                            Benchmark# is
Loading...

Top 10 Holdings

Something went wrong. Please try again after sometime!
PortfolioCompare

FAQ : ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Growth - Direct Plan

ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Growth - Direct Plan has delivered CAGR and average rolling returns as follows :

1 Year 3 Year 5 Year 9 Year
CAGR(%) 12.22 21.64 26.49 N/A
Average Rolling Returns(%) 30.35 22.31 25.91 N/A

The Current NAV of ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Growth - Direct Plan is ₹39.40.

You should look for a fund with better more consistent performance track record. Funds returns are more likely to be different than its benchmark NIFTY 500 returns, as Funds portfolio is significantly different.

ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Growth - Direct Plan fund’s expense ratio is 1.11%

The process for redemption is

  • Give a request for redemption of the number of units or the amount you want. The request will be acknowledged.
  • You will get information about the redemption and the NAV at which redeemed.
  • The amount will be deposited in the designated bank account.

The AUM of ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Growth - Direct Plan is currently ₹4,611 Crores.

The Top three stocks are Sun Pharma Inds., Cipla and Dr. Reddys Lab and account for 32% of its portfolio. Top 5 and 10 stocks of fund account for 44% and 62% of fund’s portfolio respectively.

Top three sectors of ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Growth - Direct Plan fund are Healthcare, Miscellaneous and Chemicals accounting for 97% of the total portfolio.

Funds Portfolio Quality is Very Good. It has a large proportion of Green Stocks.Since this is a Equity - Sectoral Fund - Pharma & Health Care it is comparatively safer to invest in this fund. However, since it has not consistently outperformed its benchmark index on an average 3-year rolling returns basis it is not the most suitable fund for SIP.

The category of ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Growth - Direct Plan Fund is Equity - Sectoral Fund - Pharma & Health Care.

Dharmesh Kakkad manages the ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Growth - Direct Plan Fund.

ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Growth - Direct Plan current PE ratio is 37.19 and PB ratio is 5.11

The asset allocation of ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Growth - Direct Plan is Stocks : 99.04%, Debt : 0.96% and Gold : 0%

The minimum SIP amount for ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Growth - Direct Plan is ₹100.00 and minimum lumpsum is ₹5000.00

The exit load for ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Growth - Direct Plan is 1% on or before 15 days, Nil after 15 days

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
Please wait your portfolio is updating...